申请人:Morphotek, Inc.
公开号:US10023632B2
公开(公告)日:2018-07-17
Hybridoma lines that secrete human monoclonal antibodies with high binding specificity and biological activity, particularly neutralizing activity against granulocyte-macrophage colony stimulating factor, and methods of generating the hybridoma lines are provided. Target antigens and epitopes are also provided. The antibodies may be used in therapeutic methods, for example in the treatment of cancer, infectious disease, or autoimmune disease.
提供了能分泌具有高结合特异性和生物活性(特别是对粒细胞-巨噬细胞集落刺激因子的中和活性)的人类单克隆抗体的杂交瘤系,以及产生杂交瘤系的方法。还提供了目标抗原和表位。这些抗体可用于治疗方法,例如治疗癌症、传染病或自身免疫性疾病。